Ross Sullivan, MD, FASAM completed his medical school education at SUNY Upstate Medical University in Syracuse, NY. After, he entered and finished a residency in Emergency Medicine at the same hospital. Dr. Sullivan then completed a medical toxicology fellowship at the SUNY Upstate Poison Control Center and SUNY Upstate Emergency Department. Dr. Sullivan is also board certified in Addiction Medicine. Dr. Sullivan is currently the fellowship director of the medical toxicology fellowship. He also is the director of the Upstate Emergency Medicine Opioid Bridge Clinic; the aim of this program is to initiate buprenorphine in the ED with prompt referral to an ED based clinic where patients are treated and referred to community settings. Dr. Sullivan is also the medical director for Helio Health, a community not-for-profit that offers substance use and psychiatric treatment.

Dr. Sullivan has authored several publications related to overdose and addiction, including “Cardiac conduction disturbance after loperamide abuse”, “Synthetic Cannabinoid Withdrawal”, “Baclofen overdose mimicking brain death”, and “A randomized usability assessment of simulated naloxone administration by community members.” Dr. Sullivan currently is a member of the Medical Advisory Panel to NY-OASAS (Office of Alcoholism and Substance Abuse), the NY-DOH buprenorphine work group, as well as a member of his local drug-task force.